Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Biomed Res Int ; 2020: 7239075, 2020.
Article in English | MEDLINE | ID: mdl-32420364

ABSTRACT

OBJECTIVE: To identify factors associated with increased proportion of early gastric cancer to total detected gastric cancer among patients undergoing diagnostic esophagogastroduodenoscopy. METHODS: A nationwide survey was conducted across 6 central-type and 6 municipal-type Vietnamese hospitals. A questionnaire regarding annual esophagogastroduodenoscopy volume, esophagogastroduodenoscopy preparation, the use of image-enhanced endoscopy, and number of gastric cancer diagnosed in 2018 was sent to each hospital. RESULTS: The total proportion of early gastric cancer was 4.0% (115/2857). Routine preparation with simethicone and the use of image-enhanced endoscopy were associated with higher proportion of early gastric cancer (OR 1.9, 95% CI: 1.1-3.2, p = 0.016; OR 2.7, 95% CI: 1.8-4.0, p < 0.001, respectively). Esophagogastroduodenoscopies performed at central-type hospitals were associated with higher proportion of early gastric cancer (OR 1.9, 95% CI: 1.1-3.2, p = 0.017). Esophagogastroduodenoscopies performed at hospitals with an annual volume of 30.000-60.000 were associated with higher proportion of early gastric cancer than those performed at hospitals with an annual volume of 10.000-<30.000 (OR 2.7, 95% CI: 1.6-4.8, p < 0.001) and with a volume of >60.000-100.000 (OR 2.7, 95% CI: 1.7-4.2, p < 0.001). Only four (33.3%) hospitals reported all endoscopic types of early gastric cancer. CONCLUSIONS: The detection of early gastric cancer is still challenging even for endoscopists working in regions with relatively high prevalence. The real-world evidence showed that endoscopic detection of early gastric cancer could potentially improve with simple adjustments of esophagogastroduodenoscopy protocols.


Subject(s)
Early Detection of Cancer , Endoscopy, Digestive System , Image Enhancement , Stomach Neoplasms/diagnosis , Female , Humans , Male , Middle Aged , Stomach Neoplasms/epidemiology , Vietnam/epidemiology
2.
Eur J Cancer Prev ; 28(5): 397-412, 2019 09.
Article in English | MEDLINE | ID: mdl-31386635

ABSTRACT

Gastric cancer is one of the most common causes of cancer-related mortality worldwide. The objective of this article is to review the epidemiology and biology of gastric cancer risk. This literature review explores the biological, clinical, and environmental factors that influence the rates of this disease and discuss the different intervention methods that may not only increase the awareness of gastric cancer but also increase screening in efforts to reduce the risk of gastric cancer. Helicobacter pylori infection is the primary risk factor for gastric cancer. Additional risk factors include geographical location, age, sex, smoking, socioeconomic status, dietary intake, and genetics. Primary and secondary prevention strategies such as dietary modifications and screenings are important measures for reducing the risk of gastric cancer. Interventions, such as H. pylori eradication through chemoprevention trials, have shown some potential as a preventative strategy. Although knowledge about gastric cancer risk has greatly increased, future research is warranted on the differentiation of gastric cancer epidemiology by subsite and exploring the interactions between H. pylori infection, genetics, and environmental factors. Better understanding of these relationships can help researchers determine the most effective intervention strategies for reducing the risk of this disease.


Subject(s)
Gastric Mucosa/pathology , Helicobacter Infections/epidemiology , Helicobacter pylori/pathogenicity , Smoking/epidemiology , Stomach Neoplasms/epidemiology , Age Factors , Alcohol Drinking/adverse effects , Alcohol Drinking/epidemiology , Anti-Bacterial Agents/therapeutic use , Chemoprevention/methods , Feeding Behavior/physiology , Gastric Mucosa/microbiology , Genetic Predisposition to Disease , Geography , Helicobacter Infections/drug therapy , Helicobacter Infections/microbiology , Helicobacter Infections/pathology , Humans , Metaplasia/epidemiology , Metaplasia/microbiology , Metaplasia/pathology , Metaplasia/prevention & control , Proton Pump Inhibitors/therapeutic use , Randomized Controlled Trials as Topic , Risk Factors , Sex Factors , Smoking/adverse effects , Social Class , Stomach Neoplasms/etiology , Stomach Neoplasms/pathology , Stomach Neoplasms/prevention & control , Treatment Outcome
SELECTION OF CITATIONS
SEARCH DETAIL
...